Repligen appoints new R&D SVP
Mr. Kuriyel was most recently Vice President of Applications for the single-use business unit within the Life Sciences division of Pall Corporation, a high-tech filtration, separation and purification markets company, whose acquisition by Danaher Corporation was completed in August 2015.
During his 11-year tenure at Pall, Mr. Kuriyel played a key role in expanding the Global Applications R&D function to include cell culture and single-use applications, process monitoring technologies, and process development services.
Prior to Pall, Mr. Kuriyel held various technology and applications development management roles within the bioprocess and biopharm divisions of Millipore Corporation, which was acquired by Merck KGaA in 2010.
Mr. Kuriyel received his B.S. and M.S. in Chemical Engineering from Rensselaer Polytechnic Institute, and completed coursework for the Tufts University Ph.D. program in Chemical Engineering.
He is an inventor of multiple patents and has co-authored over thirty scientific publications pertaining to bioprocessing - including separations technologies, membrane separations methods, protein processing and enhanced microfiltration techniques.
Mr. Kuriyel will take over from Dr. James Rusche, who is retiring at the end of this year following a distinguished 30-year career with the Company. ■
LATEST MOVES FROM Massachusetts
- Welch's names Lesya Lysyj president, US
- Liberty Mutual appoints Gregg Cunningham as vice president
- Voyager Therapeutics appoints Matthew P. Ottmer as COO
- Ocular Therapeutix appoints Michael Goldstein as CMO
- Battery Ventures promotes three to vice presidents
More inside POST